Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Adele Läkarkonsult AB
AB
Active
Org 5594261298
Råcksta Gårdsväg 19
General medical practice activities · NACE 8621
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 52K
-96% vs 2024
EBITDA margin
64.2%
-94% vs 2024
Equity ratio
44.5%
Financial strength
Net profit 2025
SEK 23K
-93% vs 2024
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2023
1M
0%
2024
0M
-100%
2025
Key figures
Annual report 2025
Revenue
SEK 52K
-96%
EBITDA
SEK 33K
-94%
Net profit
SEK 23K
-93%
Total assets
SEK 656K
-34%
Equity
SEK 292K
-49%
Employees
0
—
Company information
Legal name
Adele Läkarkonsult AB
Org number
5594261298
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
14 mars 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom sjukvård, bemanning som läkare samt därmed förenlig verksamhet
Contact
Address
Råcksta Gårdsväg 19
Email
gulnur.utemissova@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
0M
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
1 013
1 412
52
Staff expenses
−281
−825
−0
EBITDA
697
551
33
Depreciation & amort.
—
—
—
EBIT
697
551
33
Net financials
−0
2
−2
Profit before tax
523
415
31
Tax
−108
−86
−8
Net profit
415
328
23
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
880
991
656
Equity
440
568
292
Long-term debt
—
—
—
Short-term debt
266
110
51
Total debt
266
110
51
Financial ratios
5-year trend
EBITDA margin
64.2%
This company
15.8%
Market median
+306% vs market
2023
2025
Equity ratio
44.5%
This company
38.2%
Market median
+16% vs market
2023
2025
Return on equity
7.9%
This company
18.4%
Market median
-57% vs market
2023
2025
Net profit margin
44.6%
This company
8.1%
Market median
+451% vs market
2023
2025
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
2023
2025
Debt / equity
1.25×
This company
0.62×
Market median
-102% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-03-14 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
SS
Syeda Sarwat Jamil
Deputy Board Member
2023
GU
Gulnur Utemissova
Board of Directors
2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Adele Läkarkonsult AB also hold positions in
0
other companies.
Person
Role here
Other companies
Syeda Sarwat Jamil
Deputy Board Member
0 companies
Gulnur Utemissova
Board of Directors
0 companies